Show simple item record

dc.contributor.authorEgede, Leonard E.
dc.contributor.authorFrueh, Christopher B.
dc.contributor.authorRichardson, Lisa K.
dc.contributor.authorAcierno, Ronald
dc.contributor.authorMauldin, Patrick D.
dc.contributor.authorKnapp, Rebecca G.
dc.contributor.authorLejuez, Carl W.
dc.date.accessioned2016-08-03T18:58:03Z
dc.date.available2016-08-03T18:58:03Z
dc.date.issued2009-04-20
dc.identifier.citationEgede, L. E., Frueh, C. B., Richardson, L. K., Acierno, R., Mauldin, P. D., Knapp, R. G., & Lejuez, C. (2009). Rationale and design: telepsychology service delivery for depressed elderly veterans. Trials, 10, 22. http://doi.org/10.1186/1745-6215-10-22en_US
dc.identifier.urihttp://hdl.handle.net/1808/21265
dc.description.abstractBACKGROUND: Older adults who live in rural areas experience significant disparities in health status and access to mental health care. "Telepsychology," (also referred to as "telepsychiatry," or "telemental health") represents a potential strategy towards addressing this longstanding problem. Older adults may benefit from telepsychology due to its: (1) utility to address existing problematic access to care for rural residents; (2) capacity to reduce stigma associated with traditional mental health care; and (3) utility to overcome significant age-related problems in ambulation and transportation. Moreover, preliminary evidence indicates that telepsychiatry programs are often less expensive for patients, and reduce travel time, travel costs, and time off from work. Thus, telepsychology may provide a cost-efficient solution to access-to-care problems in rural areas. METHODS: We describe an ongoing four-year prospective, randomized clinical trial comparing the effectiveness of an empirically supported treatment for major depressive disorder, Behavioral Activation, delivered either via in-home videoconferencing technology ("Telepsychology") or traditional face-to-face services ("Same-Room"). Our hypothesis is that inhome Telepsychology service delivery will be equally effective as the traditional mode (Same-Room). Two-hundred twenty-four (224) male and female elderly participants will be administered protocol-driven individual Behavioral Activation therapy for depression over an 8-week period; and subjects will be followed for 12-months to ascertain longer-term effects of the treatment on three outcomes domains: (1) clinical outcomes (symptom severity, social functioning); (2) process variables (patient satisfaction, treatment credibility, attendance, adherence, dropout); and (3) economic outcomes (cost and resource use). DISCUSSION: Results from the proposed study will provide important insight into whether telepsychology service delivery is as effective as the traditional mode of service delivery, defined in terms of clinical, process, and economic outcomes, for elderly patients with depression residing in rural areas without adequate access to mental health services. TRIAL REGISTRATION: National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov identifier# NCT00324701).en_US
dc.publisherBioMed Centralen_US
dc.rightsCopyright © 2009 Egede et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
dc.rights.urihttp://creativecommons.org/licenses/by/2.0
dc.titleRationale and design: telepsychology service delivery for depressed elderly veteransen_US
dc.typeArticleen_US
kusw.kuauthorLejuez, Carl W.
kusw.kudepartmentPsychologyen_US
dc.identifier.doi10.1186/1745-6215-10-22en_US
kusw.oaversionScholarly/refereed, publisher versionen_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Copyright © 2009 Egede et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's license is described as: Copyright © 2009 Egede et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.